Management tracks: Medicines Co., Mallinckrodt, ArQule

The Medicines Co. (NASDAQ:MDCO) terminated the employment of Christopher Cox, EVP and chief corporate development officer, effective March 15. Details were not disclosed.

Mallinckrodt plc (NYSE:MNK) hired Bryan Reasons as CFO. He will succeed interim CFO George Kegler. Reasons

Read the full 386 word article

How to gain access

Continue reading with a
two-week free trial.